Skip to content
  • 2 Votes
    3 Posts
    867 Views
    ResearchCatR
    @Nolan Based on my reading and practice, it is 500mcg (each) daily for maintenance and up to 1mg per day for injury repair. There are some folks here who research much higher levels..
  • 2 Votes
    1 Posts
    786 Views
    RandyR
    For research use only. Not medical advice. Overview BPC-157 is a synthetic 15–amino-acid peptide studied for potential effects on tissue repair, inflammation modulation, and gastrointestinal protection. Human clinical evidence is still limited, so researchers rely on conservative dosing patterns derived from preclinical data. Subcutaneous administration is the most common route in systemic research models. Daily Dosing Protocol (Subcutaneous) Standard Daily Range 200–600 mcg once daily Escalate gradually to assess individual response and tolerance. Titration Schedule Weeks 1–2 200 mcg daily Useful as a gentle introduction, particularly when monitoring sensitivity. Weeks 3–4 400 mcg daily Represents the common working dose for generalized healing or recovery-focused protocols. Weeks 5–8+ 600 mcg daily Higher end of typical daily research use; often maintained for prolonged tissue-repair goals. Timing Once daily, at any consistent time. Some researchers prefer morning fasted dosing; others use evening to complement recovery protocols — timing is flexible. Cycle Length Standard BPC-157 research cycles: 4–8 weeks, depending on the model Optional 2–4 week break before repeating Shorter cycles may be used for acute-injury research models Chronic continuous use is less common due to limited long-term human data. Common Research Notes BPC-157 is generally well tolerated, though individual sensitivity varies. Some subjects report improvements in soft-tissue recovery, joint comfort, or GI stability within 1–3 weeks. Effects may plateau after several weeks, which is why cycles often cap at 8 weeks. Some researchers combine BPC-157 with TB-500 or GHK-Cu for injury-specific protocols.
  • 2 Votes
    20 Posts
    4k Views
    L
    I’ve seen a protocol where the starting dose was 5mg 2 to 3 times a week. Is smaller daily doses better than higher doses less often?
  • 3 Votes
    23 Posts
    3k Views
    P
    I found DSIP to be a complete waste of money regardless of dosing or protocol. Threw the rest in the trash. All hype and BS. Tried it multiple times. Insider word to the wise- Try Gastrodin 98% extract for some interesting researching in regards to relaxation and sleep. It's on Amazon and ships from China. Love the stuff. Also, I've explored high-dose melatonin, up to 100mg. quite interesting as an antioxidant. Happy researching.
  • 2 Votes
    13 Posts
    3k Views
    D
    I have a 500mg NAD bottle, dont remember if i need to add a min of 5ml bac
  • 6 Votes
    117 Posts
    19k Views
    O
    @diegoc if you have mot already gotten some my order from s1research came in wednesday with 3 1500mg vials with FUAN tops on them. Relabelled and tested to like ~1583mg.
  • 1 Votes
    2 Posts
    604 Views
    ResearchCatR
    I know sermorelin is FDA approved and very safe. I researched it for a few months when I started this adventure. I have to say results are subtle at best. As compared with CJC/Ipamorelin, which is more like a shotgun. FWIW, my sermorelin research was in line with the prescriber’s recommendation, while CJC/Ipamorelin was inline with common protocols(200-300mcg/day). I don’t completely dismiss it the way a lot of YouTubers do, but for researchers who can tolerate it and are less patient, it seems most of the other GHRH peptides give more noticeable results faster.
  • 4 Votes
    11 Posts
    2k Views
    S
    @bfuller damn son you may just be crazier than me
  • 1 Votes
    7 Posts
    1k Views
    ResearchCatR
    @Randy It’s funny; a friend of mine is on reta and like it a lot but is increasing his dose because of food noise/hunger. I use tirz and he keeps trying to get me to move to reta but I am not having trouble with food noise on a very low dose. Hence why I always say to take it slow and see what works best for you. Maybe I will try reta at some point, but right now I see no reason to mess with variables that aren’t causing problems.
  • Tesamorelin Research Dosing Protocol

    Moved Peptide Discussion tesamorelin researching
    120
    3 Votes
    120 Posts
    15k Views
    RandyR
    @MyB likely no. Not sure where the files are at the moment.
  • AOD-9604 Research Dosing Protocol

    Moved Peptide Discussion aod-9604 researching
    46
    3 Votes
    46 Posts
    7k Views
    D
    @J_Viibe said: @Randy Since the original video is was ripped away from us (Thanks alot traitor tube!!) Would you be willing to upload that AOD-9604 Reconstitution Video to Randytube or Rumble. I have been searching everywhere since hearing your mention of it on the Acetic Acid Video.. Thank you for sharing your knowledge with us all. John I can sort of sum it up as I follow what Randy had in the video. Use good Bac water and if your AOD9604 quality is good you won’t have gelling. No need for any Acetic Acid. I use 3ml of Hospira Bac water into 5mg vials of AOD-9604 and inject slowly down the side of the vial. Once all the bac water is in I slightly lift up the syringe so it sits above the liquid solution and then pull back on the syringe plunger to remove any excess air out of the vial that I am able to get and then take the syringe out of the vial completely. Then I gently roll for a couple mins, let it sit, repeat a couple more times, and I have a perfectly clear reconstituted vial of AOD-9604. I then put it through a filter and into a 3ml pen cartridge. I haven’t had a vial gel up ever since doing it this way. Edit: I feel like the real game changer here in avoiding the gelling is removing the excess air from the vial. I think that’s what used to cause the gelling for me.
  • 1 Votes
    116 Posts
    18k Views
    D
    You need more bac water 100% a 12m needle is what you use for shallow IM. You can recon with 2 ML then have a bottle of Hospira just to pull extra back water. So pull your dose lets say 2.5mg to the syringe and then pull 40-50iu of bac. Pin and test the pain… Warm the syringe before you pin. If you dont feel PIP, lower the amount of Bac water, i guarantee you will in time see that the pain in less and less
  • 0 Votes
    1 Posts
    543 Views
    RandyR
    For research use only. Not medical advice. Overview Mazdutide (LY3437943) is a dual GLP-1/glucagon agonist similar to survodutide but generally smoother and more tolerable, with a softer glucagon hit and less aggressive appetite suppression. Typical weekly exploration ranges from 2–10 mg, with gradual escalation over 8–12 weeks. It has good synergy with GLP-1/GIP agonists (e.g., tirzepatide) and is commonly used in “Ghetto Reta” stacks due to its cleaner side-effect profile. Weekly Titration Schedule Weeks 1–2: Intro Phase Dose: 2 mg once weekly Purpose: Establish baseline tolerability and assess GI sensitivity. Notes: This is a gentle entry point compared to survodutide’s 0.6 mg start. Weeks 3–4: Light Phase Dose: 4 mg once weekly Produces noticeable appetite reduction but usually without overwhelming gastric slowing. Hold at 2 mg longer if nausea persists. Weeks 5–6: Moderate Phase Dose: 6 mg once weekly This is the working dose for many research subjects. Represents a good balance of efficacy and tolerability. Weeks 7–8: Strong Phase Dose: 8 mg once weekly Strong metabolic effects emerge here. Suitable for subjects who tolerated 6 mg without significant GI burden. Weeks 9–12: Upper-Tier Phase Dose: 10 mg once weekly This is the practical “top end” for most research setups. Only escalate to 10 mg after several weeks of stability at 8 mg. Maintenance Dosing (Week 13+) Standard Maintenance 6–8 mg once weekly Best balance for long-term tolerability. High-End Maintenance 10 mg once weekly Used when the goal is more aggressive metabolic impact or retatrutide-like synergy in stacks. Frequency & Timing Once weekly, same day each week. Delayed GI effects can occur (Day 2–3), especially at ≥6 mg. When stacking with tirzepatide, escalations should be slower than this standalone schedule. Cycle Length Titration requires 8–12 weeks depending on sensitivity. Full research cycles often run 16–48 weeks, typically maintaining 6–10 mg. Common Research Notes Mazdutide is smoother and less nausea-inducing compared to survodutide. Appetite suppression is strong but less abrupt subjects often describe it as “cleaner” or “more natural.” When stacked with tirzepatide, GI effects compound; many researchers cap mazdutide at 4–6 mg in combination protocols.
  • 1 Votes
    1 Posts
    526 Views
    RandyR
    For research use only. Not medical advice. Overview Survodutide is a dual GLP-1/glucagon receptor agonist typically researched in the 0.6–6 mg weekly range, with gradual escalation over 10–12 weeks. It produces strong appetite suppression and a pronounced metabolic effect due to its glucagon activity — much more aggressive than standard GLP-1 compounds. Slow titration is essential for GI tolerability. Weekly Titration Schedule Weeks 1–2: Intro Phase Dose: 0.6 mg once weekly Purpose: Allow subjects to adapt to GLP-1 + GC stimulation. Notes: Even this low dose can feel strong for GLP-1-naive subjects. Weeks 3–4: Light Phase Dose: 1.2 mg once weekly Appetite suppression increases significantly here. Hold longer at 0.6 mg if nausea or fullness is excessive. Weeks 5–6: Moderate Phase Dose: 1.8 mg once weekly Represents a comfortable mid-range dose for many subjects. Escalate only if prior doses were well tolerated. Weeks 7–8: Strong Phase Dose: 2.4 mg once weekly This dose often produces robust metabolic effects without overwhelming tolerability. Many researchers remain here for multiple weeks before proceeding. Weeks 9–10: High Phase Dose: 3.6 mg once weekly Strong GC-driven thermogenic activity emerges. If subjects struggle at this point, step back to 2.4 mg until stable. Weeks 11–12: Upper-Tier Phase Dose: 4.8 mg once weekly This was near the top end of phase 2 obesity trial dosing. GI and appetite suppression effects intensify; titrate cautiously. Week 13+ Maintenance Two research-validated maintenance ranges: Standard Maintenance 4.8 mg once weekly Provides excellent efficacy with manageable tolerability. Maximum Maintenance 6.0 mg once weekly Represents the high end used in some modeling and extended research runs. Move to 6.0 mg only after 4.8 mg is fully tolerated for several weeks. Frequency & Timing Once weekly at a consistent time. Due to the glucagon component, many subjects experience delayed nausea (Day 2–3). Avoid rushing escalations — Survodutide hits harder per mg than typical GLP-1s. Cycle Length Titration requires 10–12 weeks minimum. Full research cycles typically last 20–48 weeks depending on goals and maintenance dose. Common Research Notes Survodutide is significantly stronger milligram-for-milligram than semaglutide or tirzepatide due to dual receptor activation. GI load increases steeply with each escalation — slow progression improves tolerability. When used in stacks (e.g., tirz + survo “Ghetto Reta”), researchers often cap survo at 0.6–1.5 mg because synergy multiplies the effect.
  • 10 Votes
    125 Posts
    20k Views
    L
    @mmp said: @brentlong I would add cagrilintide/eloralintide or switch to reta [image: 1792281138295-93d60500-3ee2-4b82-b5fa-e122f8df9930-image.jpeg] @mmp thank you!!
  • 2 Votes
    20 Posts
    2k Views
    S
    Have you tried other GLP's from vendors like Nextchems Retatrutide?
  • 2 Votes
    20 Posts
    3k Views
    S
    Question regarding reconstituting this one. I hear AA is needed to keep the pH low due to potentially getting amyloid fibrils. What is the proper way? I have never used anything but Hospira BAC water. I will not be researching this but the wife wants to so I am trying to set her up with it. Can anyone give me some help on this?
  • Reta Weekly Research Dosing Protocol

    Moved Peptide Discussion researching glp3-r
    8
    3 Votes
    8 Posts
    2k Views
    J
    Weekly uptake for my rat is as follows. .3mg, .6mg, 1mg, 2mg, 3mg, 4mg, 5mg, will be administering 6mg today. Around week 5 and on, my test subject would get really bad abdominal pain followed by more than usual bowl movement around 1-2 days before the scheduled next dose. Also, increase fiber for those who are susceptible to constipation like my subject. You are welcome. We use chia seeds soaked in water over night. Work your way up to a full dose. 8mg, 10mg, 14mg etc. See about the effects before starting Reta. But yeah, just what we’ve been doing here. Not actual advise. Also, be sure to keep up with essential vitamins like A for your eye sight. Fat soluble so take with fat. And so forth since a lot of vitamin and mineral consumption by your test subject will be at a higher rate. And that plus less food intake, recomndation is to provide nutrient dense food to your subject. Any how, hope this helps.
  • BPC-157 or Wolverine?

    Moved Peptide Discussion tb-500 bpc-157 researching wolverine
    49
    0 Votes
    49 Posts
    8k Views
    C
    @diegoc He did not bring any receipts...Not that I am protecting TB but putting him down like that and then making it appear that you are sending links that show all that you said, which they are not, is WEAK at best. If you are going to say someone is a fake and has insurance fraud etc etc then show those receipts and don't just regurgitate what you may have heard or read...It makes you look small and petty. Just my .02
  • 0 Votes
    2 Posts
    638 Views
    P
    Discussion thread for the blog post on PeptideCritic.com. Read the article: HYB’s 10mg “Retatrutide” Disaster: When Your Telegram Plug Sells You a Mystery Peptide Share your thoughts, ask questions, or continue the conversation below!